AlhoHSinclairDVuoriEHolopainenA. Abuse liability of buphrenorphine–naloxone tablets in untreated IV drug users. Drug Alcohol Depend. 2006, 88: 75–8.
2.
FontaaVBronnerC. Persistent injecting practices in subjects on methadone or buprenorphine maintenance therapy. A study of 600 cases [French]. Ann Med Interne. 2001, 152(Suppl. 7): 59–69.
3.
GuichardALertFCalderonC. Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France. Addiction. 2003, 98: 1585–97.
4.
JenkinsonRAClarkNCFryCLDobbinM. Buprenorphine diversion and injection in Melbourne, Australia: An emerging issue?Addiction. 2005, 100: 197–205.
5.
JohnsonREJaffeJHFudalaPJ. A controlled trial of buprenorphine treatment for opioid dependence. J Am Med Assoc. 1992, 267: 2750–5.
6.
LindforsNCVilpponenLRaatikainenT. Complications in the upper extremity following intra-arterial drug abuse. J Hand Surg Eur. 2010, 35: 499–504.
7.
LoHYLeongCS. Surgical complications in parenteral Subutex abusers. Singapore Med J. 2006, 47: 924–7.
8.
LooHWYamAKTanTCPengYPTeohLC. Severe upper limb complications from parenteral abuse of Subutex. Ann Acad Med Singapore. 2005, 34: 575–8.
